Barrier Therapeutics, Inc. (BTRX)

Barrier Therapeutics, Inc. is related to 0 other symbols. To date we've encountered 11 releases involving Barrier Therapeutics, Inc..

Last Price: 0.00 (0.00) - N/A, N/A

• Open: N/A
• High: N/A
• Low: N/A

Barrier Therapeutics, Inc. Options

• Barrier Therapeutics, Inc. "Business Partners"
• Barrier Therapeutics, Inc. Press Releases
• Barrier Therapeutics, Inc. News
• Barrier Therapeutics, Inc. Contact
• Barrier Therapeutics, Inc. Related (via TRYNT)

Barrier Therapeutics, Inc. "Business Partners"

A "business partner" is defined as a third party company that has co-released at least one press release with Barrier Therapeutics, Inc..

• We have not detected any "business partners" yet.

^

Barrier Therapeutics, Inc. Press Releases

• Barrier Therapeutics, Inc.: Barrier Therapeutics to Present at the Susquehanna Emerging Trends Conference (Trackbacks) (Backlinks), Wed, 25 Oct 2006 13:00:00 PDT

  PRINCETON, NJ (MARKET WIRE) Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that Geert Cauwenbergh, Ph.D., Chief Executive Officer is scheduled to present to the investment community at the Susquehanna Emerging Trends Conference.

• Barrier Therapeutics, Inc.: Barrier Therapeutics to Release Third Quarter 2006 Financial Results on October 31, 2006 (Trackbacks) (Backlinks), Tue, 24 Oct 2006 13:00:00 PDT

  PRINCETON, NJ (MARKET WIRE) Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, is scheduled to release financial results for the third quarter of 2006 on Tuesday, October 31, 2006 at approximately 3:30 p.m. Eastern Time. The Company will sponsor a conference call on October 31st at 4:30 p.m. Eastern Time to provide a company update and discuss the

• Barrier Therapeutics, Inc.: Barrier Therapeutics to Present at the European Academy of Dermatology and Venereology Congress in Rhodes, Greece (Trackbacks) (Backlinks), Thu, 5 Oct 2006 10:00:00 PDT

  PRINCETON, NJ (MARKET WIRE) Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that they will be presenting several key posters at the European Academy of Dermatology and Venerology (EADV) Congress which is being held in Rhodes, Greece from October 4-7, 2006.

• Barrier Therapeutics, Inc.: Barrier Therapeutics to Present at the UBS Global Life Sciences Conference (Trackbacks) (Backlinks), Tue, 19 Sep 2006 13:20:00 PDT

  PRINCETON, NJ (MARKET WIRE) Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that Geert Cauwenbergh, Ph.D., Chief Executive Officer, and Al Altomari, Chief Operating Officer, are scheduled to present to the investment community at the UBS Global Life Sciences Conference.

• Barrier Therapeutics, Inc.: Barrier Therapeutics, Inc. to Raise $25 Million in Registered Direct Offering (Trackbacks) (Backlinks), Fri, 15 Sep 2006 3:45:00 PDT

  PRINCETON, NJ (MARKET WIRE) Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that it has priced a registered direct offering of its common stock for approximately $25 million in gross proceeds. Under the terms of the financing, Barrier will sell approximately 4.8 million shares of its common stock at $5.25 per share to

• Barrier Therapeutics, Inc.: Barrier Therapeutics to Present at the C.E. Unterberg, Towbin Emerging Growth Conference (Trackbacks) (Backlinks), Wed, 5 Jul 2006 12:30:00 PDT

  PRINCETON, NJ (MARKET WIRE) Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that Geert Cauwenbergh, Ph.D., Chief Executive Officer, is scheduled to present to the investment community at the C.E. Unterberg, Towbin Emerging Growth Conference.

• Barrier Therapeutics, Inc.: Barrier Therapeutics Announces Board of Directors Changes (Trackbacks) (Backlinks), Tue, 27 Jun 2006 6:29:00 PDT

  PRINCETON, NJ (MARKET WIRE) Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that at its regularly scheduled meeting, the Board of Directors decided to separate the roles of Chairman of the Board and Chief Executive Officer. Geert Cauwenbergh, Ph.D. will continue as CEO and a member of the Board of Directors. Peter Ernster, an

• Barrier Therapeutics, Inc.: Barrier Therapeutics to Present at the Pacific Growth Equities 2006 Life Sciences Growth Conference (Trackbacks) (Backlinks), Mon, 5 Jun 2006 13:01:00 PDT

  PRINCETON, NJ (MARKET WIRE) Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that Geert Cauwenbergh, Ph.D., Chairman and Chief Executive Officer, is scheduled to present to the investment community at the Pacific Growth Equities 2006 Life Sciences Growth Conference.

• Barrier Therapeutics, Inc.: Barrier Therapeutics to Present at Bank of America 2006 Health Care Conference (Trackbacks) (Backlinks), Wed, 10 May 2006 13:00:00 PDT

  PRINCETON, NJ (MARKET WIRE) Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that Geert Cauwenbergh, Ph.D., Chairman and Chief Executive Officer is scheduled to present to the investment community at the Bank of America 2006 Health Care Conference.

• Barrier Therapeutics, Inc.: Barrier Therapeutics to Present at Morgan Stanley Global Healthcare Unplugged Conference (Trackbacks) (Backlinks), Wed, 3 May 2006 10:00:00 PDT

  PRINCETON, NJ (MARKET WIRE) Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that Geert Cauwenbergh, Ph.D., Chairman and Chief Executive Officer, is scheduled to participate in the Morgan Stanley Global Healthcare Unplugged Conference.

^

Barrier Therapeutics, Inc. News

• Navigating the Micro-Cap Biotech Minefield (at Seeking Alpha), Sun, 23 Nov 2008 15:26:18 Etc/GMT
• Agile Therapeutics Appoints Industry Expert, Al Altomari, as Chairman of Its Board of Directors (Marketwire), Tue, 12 Aug 2008 12:01:00 Etc/GMT
• BARRIER THERAPEUTICS INC Files SEC form 8-K, Termination of a Material Definitive Agreement (EDGAR Online), Thu, 7 Aug 2008 10:01:20 Etc/GMT
• BARRIER THERAPEUTICS INC Files SEC form 8-K, Changes in Control or Registrant (EDGAR Online), Tue, 5 Aug 2008 13:26:20 Etc/GMT
• Stockpickr's Activist Track Stocks (at TheStreet.com), Wed, 30 Jul 2008 15:28:00 Etc/GMT
• Barrier Therapeutics, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to the Stiefel Laboratories, Inc. Proposal to Acquire Barrier Therapeutics, Inc. (GlobeNewswire), Tue, 29 Jul 2008 13:23:18 Etc/GMT
• Barrier Therapeutics Introduces Dual-Component Xolegel CorePak(TM) for Seborrheic Dermatitis (Marketwire), Mon, 28 Jul 2008 12:30:00 Etc/GMT
• Barrier Taken Down (at Motley Fool), Tue, 24 Jun 2008 19:04:37 Etc/GMT
• BARRIER THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh (EDGAR Online), Tue, 24 Jun 2008 10:02:02 Etc/GMT
• Stiefel Laboratories Wraps Up Barrier (at Forbes.com), Mon, 23 Jun 2008 20:20:06 Etc/GMT
• Monday's Winners & Losers: MBIA (at TheStreet.com), Mon, 23 Jun 2008 20:12:33 Etc/GMT
• Health Winners & Losers: Barrier Therapeutics (at TheStreet.com), Mon, 23 Jun 2008 20:08:27 Etc/GMT
• Barrier Therapeutics, Inc. and Stiefel Laboratories, Inc. Sign Definitive Merger Agreement (GlobeNewswire), Mon, 23 Jun 2008 13:00:00 Etc/GMT
• No Barrier to Deals Like This (at Motley Fool), Wed, 28 May 2008 19:37:18 Etc/GMT
• Barrier Therapeutics Announces Agreement with Procter & Gamble to Market Xolegel (ketoconazole, USP) Gel, 2 Percent With Head & Shoulders Shampoo as Xolegel Duo (GlobeNewswire), Thu, 22 May 2008 11:30:00 Etc/GMT
• BARRIER THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report (EDGAR Online), Fri, 9 May 2008 18:55:53 Etc/GMT
• BARRIER THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi (EDGAR Online), Thu, 1 May 2008 17:31:13 Etc/GMT
• BARRIER THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and (EDGAR Online), Tue, 29 Apr 2008 20:18:22 Etc/GMT
• Barrier Therapeutics Announces First Quarter 2008 Financial Results (GlobeNewswire), Tue, 29 Apr 2008 20:00:00 Etc/GMT
• Barrier Therapeutics to Present At the Deutsche Bank 33rd Annual Health Care Conference (GlobeNewswire), Mon, 28 Apr 2008 11:30:00 Etc/GMT

^

Barrier Therapeutics, Inc. Contact

• Contact:
  Barrier Therapeutics, Inc.
  Anne M. VanLent
  609-945-1202
  
  Noonan Russo
  Diane Perry
  212-845-4239
  
  

TRYNT Related

• TRYNT did not suggest any related symbols

^

What is a Stock Cloud?

A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.